European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally. The company offers ADAM, a software solution for imaging; R/F solutions, including PLATINUM NEO, a solution that revolutionizes the R/F workflow through an interface and AI-powered image processing; OPTIMA, a performance remote-controlled table designed to provide, imaging solution for radiography and fluoroscopy examinations; and Optima, a imaging solution for radiography and fluoroscopy examinations. It also provides bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024. European Medical Solutions was founded in 1997 and is headquartered in Brussels, Belgium. European Medical Solutions is a subsidiary of Diagnostic Medical Systems S.A.…
REG - Glazer Capital, LLC Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc
European Medical Solutions (EBR: ALEMS) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 119 employees.
The shares were at 3.500 EUR on 20 November 2026, down 30.0% over 52 weeks. Its 52-week range is 3.400 EUR to 5.500 EUR: the price is 36.4% below the high and 2.9% above the low.
At a market capitalisation of 14.81M EUR, it trades at 7.6 times trailing earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.1, a discount of 77% for ALEMS.
European Medical Solutions reports return on equity of 15.3%, an operating margin of 5.6% and revenue down 5.8% year over year.
Its debt exceeds its cash by 16.18M EUR, a debt-to-equity ratio of 1.58. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.
No upcoming events tracked.